The influence of market exclusivity on drug availability and medical innovations-Reference-Cited by-同舟云学术

The influence of market exclusivity on drug availability and medical innovations

Published:2007-09 Issue:3 Volume:9 Page:E312-E316
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Glover Gregory J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/aapsj0903034.pdf

Reference28 articles.

1. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States. 2006. Table 27. 2006; Available at: http://www.cdc.gov/nchs/data/hus/tables/2003/03hus027.pdf. Accessed November 22, 2006.

2. Cech TR. Fostering innovation and discovery in biomedical research. JAMA. 2005;294:1390.

3. Pharmaceutical Research and Manufacturers of America (PhRMA). Pharmaceutical Industry Profile 2005. Available at: www.phrma.com. Accessed November 22, 2006.

4. US Const, Art 1 §8 cl 8.

5. Patent Act 35 USC §271(a) (2006).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensions of indication throughout the drug product lifecycle: a quantitative analysis;Drug Discovery Today;2016-02

2. Sources of innovation: an assessment of intellectual property;Drug Discovery Today;2015-05

3. Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy;International Series in Quantitative Marketing;2013-10-26

4. Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984;Acta Pharmaceutica Sinica B;2013-09

5. Effects of new formulation strategy on life cycle management in the US pharmaceutical industry;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2013-09